Elsevier Evidence-based Medicine Center Selects Doctor Evidence for Digital Clinical Evidence Platform

Doctor Evidence to provide a comprehensive clinical evidence platform to support Elsevier Clinical Solutions' global clinical product suite

Philadelphia, PA, July 23, 2014

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that Elsevier Clinical Solutions' Evidence-based Medicine Center (EBM Center) has reached an agreement with Doctor Evidence LLC (DRE) to provide the platform engine supporting the Clinical Solutions' suite of evidence-based clinical solutions.

"Doctor Evidence is tremendously excited to be working with the Elsevier EBM Center in providing physicians and patients with truly evidence-based clinical data," said Robert Battista, CEO and Co-Founder of Doctor Evidence. "Consistent with our company values, the most gratifying partnerships are the ones that have the potential to directly impact patients and improve their outcomes and well-being through the use of evidence. This engagement with the Elsevier EBM Center is one of those partnerships."

DRE will configure databases with high quality data from the medical literature pertinent to key clinical topics for the EBM Center, assuring that all the information is reliably and easily managed through a robust technology platform that is compliant with the standards set forth by the world's leading authorities on evidence-based medicine. DRE's Digital Outcome Conversion (DOC™) suite of products will provide the evidence foundation supporting Elsevier solutions such as ClinicalKey, InOrder by Elsevier, and other point-of-care decision support resources.

"Our suite of clinical solutions addresses some of the biggest challenges in healthcare by making clinical evidence available to professionals and patients at the right time and in the right setting," said David Goldmann, MD, Vice President and Chief Medical Quality Assurance Officer at Elsevier Clinical Solutions. Goldmann heads up the EBM Center.

"The EBM Center is charged with ensuring that Elsevier's clinical content is as high-quality and evidence-based as it can be. Among the many companies claiming to be able to meet our needs for extracting and synthesizing clinical data to support our activities, Doctor Evidence stands alone with its combination of people, process and technology," Goldmann said. "Doctor Evidence's platform will allow our team of methodologists and subject matter experts to conduct powerful analyses and to continually update the body of evidence supporting our clinical products."


About Doctor Evidence, LLC
Doctor Evidence is a specialty software platform and services company aimed to assist stakeholders across the healthcare ecosystem to make and inform clinical decisions with the most relevant medical evidence. The Doctor Evidence methodology uses a Digital Outcome Conversion (DOC™) approach of taking data from static sources and to transform it into reusable, dynamic databases. The Doctor Evidence software platform empowers both public and private sector clients via programs like its GROWTH Collaborative.

About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com

Media contact
Christopher Capot
Director, Corporate Relations
+1 212 633 3164